BlackThorn Therapeutics
Latest round
- Series B
Last raised
- Jun 2019
Total raised
- $130M
Investors
- 11
About BlackThorn Therapeutics
BlackThorn Therapeutics, Inc.Founded in 2013 and headquartered in San Francisco, US, BlackThorn Therapeutics, Inc. specializes in the development of therapeutic solutions for neurological and psychiatric conditions.BlackThorn Therapeutics develops targeted therapies designed to treat various neurological and psychiatric disorders.00 mn. The company aims to penetrate new geographical markets, particularly targeting Europe and parts of Asia by 2025, to broaden their impact and reach within the mental health space.
Who invested in BlackThorn Therapeutics
11 investors across 3 rounds
See all investors in BlackThorn Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BlackThorn Therapeutics
Who invested in BlackThorn Therapeutics?
BlackThorn Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BlackThorn Therapeutics raised?
BlackThorn Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BlackThorn Therapeutics last raise money?
BlackThorn Therapeutics's most recent round on record is a Series B, in Jun 2019.
What does BlackThorn Therapeutics do?
BlackThorn Therapeutics is a pharmaceuticals company.
Where is BlackThorn Therapeutics headquartered?
BlackThorn Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like BlackThorn Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at BlackThorn Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like BlackThorn Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.